Clinical and tumour biology studies of Diffuse Large B-cell Lymphoma : with emphasis on comorbidity, toxicity and outcome

Charlott Mörth

Clinical and tumour biology studies of Diffuse Large B-cell Lymphoma : with emphasis on comorbidity, toxicity and outcome

2020

Charlott Mörth

Diffuse large B-cell lymphoma (DLBCL) is curable in around 70% when treated with standard immunochemotherapy R- CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone). Treatmen ...

Keywords:

Diffuse large B-cell lymphoma
Internal medicine
Vincristine
Doxorubicin
Rituximab
Cyclophosphamide
Lymphoma
Medicine
Prednisone
CHOP
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations